Dr. Izzy’s FDA Radar

Companies

20 matching companies

ALNYLAM PHARMACEUTICALS, INC.

February 2027

ALN-2232 · clinical data

View details

Biotech

Reported cash

USD 1,754,340,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

AMGEN INC

By year-end 2026

ABP 206

View details

Biotech

Reported cash

USD 13,190,000,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

ARVINAS, INC.

mid 2027

ARV-393 · additional monotherapy data

View details

Biotech

Reported cash

USD 88,000,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

Axsome Therapeutics, Inc.

Q1 2027

ENGAGE

View details

Biotech

Reported cash

USD 313,859,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

Beam Therapeutics Inc.

No verified upcoming catalyst
View details

Biotech

Reported cash

USD 213,267,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

Beta Bionics, Inc.

No verified upcoming catalyst
View details

Medtech

Reported cash

USD 81,551,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

Mint ACE Pump

510(k) Cleared · Oct 21, 2026

BIOMARIN PHARMACEUTICAL INC

2027

BMN 333 · clinical data

View details

Biotech

Reported cash

USD 736,007,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

Guardant Health, Inc.

No verified upcoming catalyst
View details

Medtech

Reported cash

USD 1,026,848,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

Guardant360 CDx

PMA Supplement Approved · Sep 18, 2026

INSMED Inc

January 28, 2027

ARIKAYCE · Mycobacterium avium complex

View details

Biotech

Reported cash

USD 396,563,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

Intellia Therapeutics, Inc.

March 10, 2027

lonvo-z

View details

Biotech

Reported cash

USD 156,098,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

INTUITIVE SURGICAL INC

No verified upcoming catalyst
View details

Medtech

Reported cash

USD 2,978,100,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

Form 8-K filed

8-K · Nov 2, 2026

IONIS PHARMACEUTICALS INC

2027

Sefaxersen IMAgINATION data

View details

Biotech

Reported cash

USD 296,303,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

Zanvastro

Novel Drug Approved · Sep 3, 2026

Kymera Therapeutics, Inc.

By year-end 2026

BROADEN2

View details

Biotech

Reported cash

USD 373,374,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

PTC THERAPEUTICS, INC.

No verified upcoming catalyst
View details

Biotech

Reported cash

USD 508,894,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

REGENERON PHARMACEUTICALS, INC.

February 2027

Ordspono

View details

Biotech

Reported cash

USD 3,659,100,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

Form 8-K filed

8-K · Oct 30, 2026

Revolution Medicines, Inc.

H1 2027

Colorectal cancer clinical data update

View details

Biotech

Reported cash

USD 615,908,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

Rasonque

Novel Drug Approved · Aug 26, 2026

Sarepta Therapeutics, Inc.

No verified upcoming catalyst
View details

Biotech

Reported cash

USD 472,760,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

Tempus AI, Inc.

No verified upcoming catalyst
View details

Medtech

Reported cash

USD 590,479,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

Tempus ECG-MR

510(k) Cleared · Sep 25, 2026

VERTEX PHARMACEUTICALS INC / MA

November 30, 2026

povetacicept

View details

Biotech

Reported cash

USD 4,979,300,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

Viking Therapeutics, Inc.

2027

VK2735 · maintenance Part 2 results

View details

Biotech

Reported cash

USD 677,609,000

Sep 30, 2026

SEC filing

Cash verified Nov 16, 2026

No verified development in tracked sources

Independent tracker · SEC identities · Verified FDA records